Axsome Therapeutics (AXSM) Raw Materials (2022 - 2025)
Historic Raw Materials for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $12.4 million.
- Axsome Therapeutics' Raw Materials rose 6048.52% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 6048.52%. This contributed to the annual value of $9.5 million for FY2024, which is 7240.69% up from last year.
- Axsome Therapeutics' Raw Materials amounted to $12.4 million in Q3 2025, which was up 6048.52% from $11.7 million recorded in Q2 2025.
- Axsome Therapeutics' Raw Materials' 5-year high stood at $12.4 million during Q3 2025, with a 5-year trough of $2.1 million in Q3 2022.
- Its 4-year average for Raw Materials is $6.8 million, with a median of $5.6 million in 2024.
- Per our database at Business Quant, Axsome Therapeutics' Raw Materials soared by 12377.68% in 2023 and then skyrocketed by 4590.85% in 2024.
- Quarter analysis of 4 years shows Axsome Therapeutics' Raw Materials stood at $2.5 million in 2022, then soared by 123.78% to $5.5 million in 2023, then surged by 72.41% to $9.5 million in 2024, then soared by 30.34% to $12.4 million in 2025.
- Its Raw Materials was $12.4 million in Q3 2025, compared to $11.7 million in Q2 2025 and $11.5 million in Q1 2025.